Skip to main content

Table 1 Patient’s baseline characteristics at diagnosis of all patients

From: Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients

CharacteristicsRDW(%)P valuePLT(×109/L)P valueHB(g/dL)P value
> 14.35(n = 93,%)14.35(n = 256,%)> 126.5(n = 305,%)126.5(n = 44,%)low(n = 187,%)high(n = 162,%)
Age > 6038(40.86)108(42.19)0.824126(41.31)20(45.45)0.60288(47.06)58(35.80)0.034
Gender (male)43(46.23)148(57.81)0.055168(55.08)23(52.27)0.72691(48.66)100(61.73)0.014
B symptoms (present)37(39.78)66(25.78)0.01184(27.54)19(43.18)0.03373(39.04)30(18.52)< 0.001
Ann Arbor stage III/IV63(67.74)111(43.36)< 0.001143(46.89)31(70.45)0.003117(62.57)57(35.19)< 0.001
ECOG PS251(54.83)49(19.14)< 0.00175(24.59)16(36.36)0.09675(40.11)16(9.88)< 0.001
Serum LDH level246u/l58(62.37)88(34.38)< 0.001122(40.00)24(54.54)0.01397(51.87)49(30.25)< 0.001
Extranodal sites234(36.56)52(20.31)0.00269(22.62)17(38.64)0.02157(30.48)29(17.90)0.007
BM involvement9(9.68)6(2.34)0.00711(3.61)4(9.09)0.20111(5.88)4(2.47)0.192
IPI > 244(47.31)57(22.27)< 0.00183(27.21)18(40.91)0.06174(39.57)27(16.67)< 0.001